Literature DB >> 8373774

Mutagenesis of structural half-cystine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione.

X Ren1, M Björnstedt, B Shen, M L Ericson, A Holmgren.   

Abstract

A human thioredoxin cDNA was modified to optimize Escherichia coli expression and subcloned into the plasmid pACA, a vector for T7 RNA polymerase-directed expression. The substitution of structural (noncatalytic) half-cystines in human thioredoxin (hTrx) was made by site-directed mutagenesis. The recombinant wild-type (wt) hTrx and its mutant C61S, C72S, and C61S/C72S were expressed and purified to homogeneity. Characterization of the wt and mutant hTrx was done with respect to redox activity with thioredoxin reductase (TR), tryptophan fluorescence, and effects of incubation with GS-Se-SG, which is believed to be the major metabolite of inorganic selenium compounds in mammalian tissues. The Km and kcat of wild-type hTrx for human placenta thioredoxin reductase (HP-TR) at pH 7.0 were 2.0 microM and 2800 min-1, respectively. The mutant proteins C61S, C72S, and C61S/C72S had Km and kcat values similar to those of the wt thioredoxin. Tryptophan fluorescence measurements showed that the wt and mutant proteins had similar stability to a denaturing agent. Incubation of fully reduced thioredoxin with 0.1 molar equivalent of GS-Se-SG resulted in continued oxidation of SH groups. After 3.5 h only 0.5 of initially 4.6 SH groups/thioredoxin remained. With the oxidized protein, a pronounced lag phase in thioredoxin reductase-dependent insulin disulfide reduction was present. Disulfide-linked dimers of the protein were present. The results clearly showed that noncatalytic cysteine residues in hTrx were oxidized accompanied by dimerization and inactivation. The activities of the mutant proteins C72S and C61S/C72S were unchanged after 3 h of incubation with GS-Se-SG. No dimer appeared of the C72S thioredoxin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373774     DOI: 10.1021/bi00088a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Crystal structure of the human thioredoxin reductase-thioredoxin complex.

Authors:  Karin Fritz-Wolf; Sebastian Kehr; Michaela Stumpf; Stefan Rahlfs; Katja Becker
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

2.  Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.

Authors:  Rajib Sengupta; Lucia Coppo; Pradeep Mishra; Arne Holmgren
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

3.  Probing the chemistry of thioredoxin catalysis with force.

Authors:  Arun P Wiita; Raul Perez-Jimenez; Kirstin A Walther; Frauke Gräter; B J Berne; Arne Holmgren; Jose M Sanchez-Ruiz; Julio M Fernandez
Journal:  Nature       Date:  2007-11-01       Impact factor: 49.962

4.  Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.

Authors:  L Zhong; E S Arnér; A Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.

Authors:  Farnaz Zahedi Avval; Arne Holmgren
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

6.  Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase.

Authors:  Irina Pader; Rajib Sengupta; Marcus Cebula; Jianqiang Xu; Jon O Lundberg; Arne Holmgren; Katarina Johansson; Elias S J Arnér
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver.

Authors:  Jun Lu; Liangwei Zhong; Maria Elisabet Lönn; Raymond F Burk; Kristina E Hill; Arne Holmgren
Journal:  FASEB J       Date:  2009-04-07       Impact factor: 5.191

8.  Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.

Authors:  Marike W van Gisbergen; Marcus Cebula; Jie Zhang; Astrid Ottosson-Wadlund; Ludwig Dubois; Philippe Lambin; Kenneth D Tew; Danyelle M Townsend; Guido R M M Haenen; Marie-José Drittij-Reijnders; Hisao Saneyoshi; Mika Araki; Yuko Shishido; Yoshihiro Ito; Elias S J Arnér; Hiroshi Abe; Ralf Morgenstern; Katarina Johansson
Journal:  Mol Pharm       Date:  2016-04-28       Impact factor: 4.939

9.  Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.

Authors:  Victoria Hellberg; Inger Wallin; Sofi Eriksson; Emma Hernlund; Elin Jerremalm; Maria Berndtsson; Staffan Eksborg; Elias S J Arnér; Maria Shoshan; Hans Ehrsson; Göran Laurell
Journal:  J Natl Cancer Inst       Date:  2008-12-30       Impact factor: 13.506

10.  Thioredoxin A active-site mutants form mixed disulfide dimers that resemble enzyme-substrate reaction intermediates.

Authors:  Thijs R H M Kouwen; Juni Andréll; Rianne Schrijver; Jean-Yves F Dubois; Megan J Maher; So Iwata; Elisabeth P Carpenter; Jan Maarten van Dijl
Journal:  J Mol Biol       Date:  2008-04-10       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.